Meningitis Outbreak 2012

Number of Fungal Meningitis Cases Grows In Indiana

by Staff | October 31st, 2012

October 31, 2012

According to a story released by WIBQ News, a total of 40 cases of fungal meningitis infections and two deaths have been reported to date in Indiana. More than 1,500 patients statewide were exposed to the outbreak.

On October 16, a lawsuit was filed on behalf on a Columbus, Indiana, woman, who claims she was infected with the disease after receiving three of the tainted injection in her back while receiving pain therapy at a clinic in her hometown. The clinic was one of only six facilities in Indiana to receive the injections that were manufactured by the New England Compounding Center located in Framingham, Massachusetts. The lawsuit is seeking an unspecified amount in damages as the woman is only showing symptoms of the Indiana Drug Injury and has not been diagnosed yet.

The Indiana Attorney General’s office is also taking action in response to the outbreak by filing a lawsuit against the manufacturer of the tainted drugs. The complaint file by the AG is seeking to suspend the compounding center’s license for 90 days.

The Indiana medical malpractice lawyers with Fleschner, Stark, Tanoos & Newlin understand how complicated the process of filing a claim can be after suffering a drug injury. That’s why the firm is here to answer any questions you may have about your legal rights concerning a claim you are preparing to file.

12 Cases of Meningitis Confirmed In Indiana By The CDC

by Staff | October 10th, 2012

October 10, 2012

With roughly 18,000 doses of an injectable steroid being voluntarily recalled due to contamination, the Centers for Disease Control and Prevention (CDC) announced 12 cases of infection have been reported in Indiana. According to NECN News, the approximately 1,500 patients who were exposed to the deadly strain of Aspergillus Meningitis received the injections at six different healthcare facilities across the state located in Elkhart, Evansville, Fort Wayne, South Bend, Terre Haute, and Columbus.

The injectable steroid, methylprednisolone acetate, was manufactured by the New England Compounding Center in Framingham, Massachusetts, where it was contaminated with the common leaf fungus. Patients who contracted the fungal meningitis will experience headaches, nausea, dizziness, and fever. They may also experience stroke-like symptoms due to inflammation around the brain and spinal cord. Patients exposed to the disease have been instructed to seek medical care immediately if they display any symptoms of the drug injury.

So far, the outbreak has been responsible for a dozen deaths, and more than 119 people have been infected across 23 states. Experts expect the number of infected patients to continue to rise over the next several weeks.

The Indiana Disability Lawyers with Fleschner, Stark, Tanoos & Newlin believe drug manufacturers have a responsibility to supply consumers with products that are safe. That’s why the firm would urge anyone who has suffered negative effects from medication given by a healthcare professional to discuss your rights with a qualified attorney immediately.